ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals A retrospective analysis of patients presenting with first acute coronary syndromes

GÜNTEKİN Ü., Tosun V., Kilinc A. Y., Saydam G., Korucuk N., BOZDEMIR M. N.

MEDICINE, cilt.97, sa.39, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 97 Sayı: 39
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1097/md.0000000000012225
  • Dergi Adı: MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: angina pectoris, dyslipidemia, LDL, lipoproteins, non-ST elevation myocardial infarction, ST elevation myocardial infarction, DENSITY-LIPOPROTEIN CHOLESTEROL, CARDIOVASCULAR OUTCOMES, DISCONTINUATION, ADHERENCE, MORTALITY, METAANALYSIS, GUIDELINES, MANAGEMENT, THERAPY, STATINS
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Statin nonadherence or discontinuation is associated with increased cardiovascular events. Many factors related to the physicians or the patients are influential in this. We aimed to compare the compliance with statin therapy between the patients who first presented with ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina pectoris (UA) based on the target achievement according to the current dyslipidemia guidelines.